SCHEMBL1102891

SCHEMBL1102891

c1ccc(-c2c3ccccc3c(N3c4ccccc4Oc4ccccc43)c3cnccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
TNF P01375 1/20 0.33
AKT1 P31749 2/20 0.33
HTR6 P50406 2/20 0.33
MAP2 P11137 1/20 0.33
ACHE P22303 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
IKBKB O14920 1/20 0.33
AURKA O14965 1/20 0.33
CHUK O15111 1/20 0.33
ALDH1A1 P00352 1/20 0.33
PIM1 P11309 1/20 0.33
TOP1 P11387 1/20 0.33
GABRA1 P14867 1/20 0.33
IDO1 P14902 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102546 0.90 MAOA (0.39) CDK4CCND1ACHEKDM4EGABRP
SCHEMBL1102850 0.86 CYP11B1 (0.38) TDO2SMN1; SMN2NPC1RAB9ACDK8
SCHEMBL1102651 0.83 CYP11B1 (0.36) ALOX5TNFAKT1MAP2ATM
SCHEMBL1102658 0.83 ACHE (0.40) ALOX5TNFMAP2ACHEIDO1
SCHEMBL1102713 0.83 TNF (0.39) CDK4CCND1TNFKDM4EALDH1A1
SCHEMBL1102874 0.82 LMNA (0.33) ALOX5CDK4CCND1TNFAKT1
SCHEMBL1102773 0.81 ALOX5 (0.33) ALOX5TNFAKT1HTR6MAP2
SCHEMBL1103072 0.79 HTT (0.33) CDK4CCND1AKT1KDM4EALDH1A1
SCHEMBL13158711 0.78 PRKDC (0.34) SMN1; SMN2NPC1RAB9AP2RX4
SCHEMBL1102524 0.78 CDK8 (0.34) CDK4CCND1ACHEKDM4EGABRP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 ALOX5 9/4885CDK4 1577/4885CCND1 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.